HANA BIOSCIENCES, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Restricted Stock Agreement (this “Agreement”) made effective as of May 9, 2006, is by and between Hana Biosciences, Inc., a Delaware corporation having a place of business at 400 Oyster Point Boulevard, Suite 215, South San Francisco, California 94080 (the “Company”), and Gregory I. Berk (“Executive”).
HANA BIOSCIENCES, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Restricted Stock Agreement (this “Agreement”) made effective as of June 30, 2006, is by and between Hana Biosciences, Inc., a Delaware corporation having a place of business at 400 Oyster Point Boulevard, Suite 215, South San Francisco, California 94080 (the “Company”), and Mark J. Ahn (“Executive”).
TRANSACTION AGREEMENTTransaction Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Washington
INEX PHARMACEUTICALS CORPORATION, a company amalgamated under the laws of British Columbia company and having an office at #200 - 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada V5J 5J8
AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENTEmployment Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 3 made as of June 30, 2006 (the “Amendment”), to the EMPLOYMENT AGREEMENT dated November 1, 2003, as amended October 21, 2004 and December 16, 2005 (the “Agreement”), by and between Hana Biosciences, Inc. (formerly Hudson Health Sciences, Inc.), a Delaware corporation (the “Company”), and Mark J. Ahn, Ph.D. (“Executive”).
HANA BIOSCIENCES, INC. Amendment to Stock Option AgreementsStock Option Agreements • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations
This Amendment to Stock Option Agreements (this “Amendment”) is made and entered into as of the 30th day of June, 2006, between Mark J. Ahn (“Optionee”) and Hana Biosciences, Inc., a Delaware corporation (the “Company”).
THIS AMENDED AND RESTATED LICENSE AGREEMENT is made as of April 3, 2003 between: and acknowledged and agreed to by: RECITALS:License Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • New York
ContractSublicence Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • British Columbia
Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”), dated as of May 6, 2006, by and among Hana Biosciences, Inc., a Delaware corporation (the “Company”), and Inex Pharmaceuticals Corporation, a British Columbia Corporation, (the “Stockholder”).
SubleaseSublease Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations
Sublessor is the lessee under a written lease dated November 3, 1999 wherein Mountain Cove Tech Center LLC ("Lessor) leased to Sublessor the real property located in the City of South San Francisco, County of San Mateo, State of California, described as7000 Shoreline Court. ("Master Premises"). Said lease has been amended by the following amendments: see Amendment to Lease dated October 1, 2004, by and between Mountain Cove Tech. Center LLC and MJ Research Incorporated; said lease and amendments are herein collectively referred to as the "Master Lease" and are attached hereto as Exhibit "A."
LICENSE AGREEMENT BETWEEN INEX PHARMACEUTICALS CORPORATION AND HANA BIOSCIENCES, INC.License Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Washington
INEX PHARMACEUTICALS CORPORATION, a company duly incorporated under the laws of British Columbia having an office at #200 - 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada V5J 5J8
HANA BIOSCIENCES, INC. Amendment to Stock Option AgreementStock Option Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations
This Amendment to Stock Option Agreement (this “Amendment”) is made and entered into as of the 30th day of June, 2006, between Fred L. Vitale (“Optionee”) and Hana Biosciences, Inc., a Delaware corporation (the “Company”).
HANA BIOSCIENCES, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • August 14th, 2006 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Restricted Stock Agreement (this “Agreement”) made effective as of June 30, 2006, is by and between Hana Biosciences, Inc., a Delaware corporation having a place of business at 400 Oyster Point Boulevard, Suite 215, South San Francisco, California 94080 (the “Company”), and Fred L. Vitale (“Executive”).
